Bedside to gene and back in idiopathic pulmonary fibrosis

New England Journal of Medicine

Volumn 368, Issue 23, 2013, Pages 2228-2230

  Cookson, William O C ^a   Moffatt, Miriam F ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; MUCIN 5B; SURFACTANT PROTEIN C; TELOMERASE REVERSE TRANSCRIPTASE;

AGE; ASBESTOSIS; CHROMOSOME 11P; DRUG MEGADOSE; EDITORIAL; FIBROSING ALVEOLITIS; GENE; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; HEREDITY; HUMAN; MUC5B GENE; PENETRANCE; PRIORITY JOURNAL; SFTPA2 GENE; SFTPC GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TERC GENE; TERT GENE;

EID: 84878563168     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1304758     Document Type: Article

References (10)

1. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824.
2. Navaratnam V, Fleming KM, West J, et al. The rising incidence of idiopathic pulmonary fibrosis in the U.K. Thorax 2011;66:462-7.
3. Lawson WE, Loyd JE, Degryse AL. Genetics in pulmonary fibrosis - familial cases provide clues to the pathogenesis of idiopathic pulmonary fibrosis. Am J Med Sci 2011;341:439-43.
4. Seibold MA, Wise AL, Speer MC, et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med 2011;364:1503-12.
5. Fingerlin TE, Murphy E, Zhang W, et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet 2013 April 14 (Epub ahead of print).
6. Hunninghake GM, Hatabu H, Okajima Y, et al. MUC5B promoter polymorphism and interstitial lung abnormalities. N Engl J Med 2013;368:2192-200.
7. Peljto AL, Steele MP, Fingerlin TE, et al. The pulmonary fibrosis-associated MUC5B promoter polymorphism does not influence the development of interstitial pneumonia in systemic sclerosis. Chest 2012;142:1584-8.
8. Corrin B, Dewar A, Rodriguez-Roisin R, Turner-Warwick M. Fine structural changes in cryptogenic fibrosing alveolitis and asbestosis. J Pathol 1985;147:107-19.
9. Shulgina L, Cahn AP, Chilvers ER, et al. Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial. Thorax 2013;68:155-62.
10. The Idiopathic Pulmonary Fibrosis Clinical Research Network. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 2012;366:1968-77.